Marc Capet

445 total citations
26 papers, 351 citations indexed

About

Marc Capet is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Marc Capet has authored 26 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Immunology and 6 papers in Organic Chemistry. Recurrent topics in Marc Capet's work include Receptor Mechanisms and Signaling (14 papers), Mast cells and histamine (10 papers) and Chemical Synthesis and Analysis (5 papers). Marc Capet is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Mast cells and histamine (10 papers) and Chemical Synthesis and Analysis (5 papers). Marc Capet collaborates with scholars based in France, Germany and Netherlands. Marc Capet's co-authors include Jean‐Charles Schwartz, Adam Doble, Thierry Calmels, Isabelle Berrebi‐Bertrand, Nicolas Levoin, Philippe Robert, Holger Stark, Jeanne‐Marie Lecomte, Marie‐Claude Burgevin and Nadine Daniel and has published in prestigious journals such as Analytical Biochemistry, Annals of the New York Academy of Sciences and British Journal of Pharmacology.

In The Last Decade

Marc Capet

25 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Capet France 12 206 101 89 66 46 26 351
Mark J. Gemkow Germany 11 231 1.1× 117 1.2× 115 1.3× 46 0.7× 30 0.7× 15 389
Steffen Pockes Germany 11 312 1.5× 127 1.3× 136 1.5× 59 0.9× 63 1.4× 38 426
Norihiro Takenaga Japan 12 176 0.9× 80 0.8× 34 0.4× 96 1.5× 15 0.3× 25 370
Sandra L. Cockerham United States 10 188 0.9× 44 0.4× 210 2.4× 68 1.0× 23 0.5× 25 521
Michael Berlin United States 10 191 0.9× 139 1.4× 24 0.3× 91 1.4× 16 0.3× 19 349
Albert J. Uveges United States 9 401 1.9× 72 0.7× 198 2.2× 46 0.7× 18 0.4× 11 658
Rolf Hohlweg Denmark 10 217 1.1× 60 0.6× 164 1.8× 92 1.4× 8 0.2× 17 344
Kamil Kuder Poland 16 406 2.0× 246 2.4× 122 1.4× 159 2.4× 98 2.1× 47 640
Lawrence A. Black United States 13 337 1.6× 281 2.8× 45 0.5× 135 2.0× 14 0.3× 16 510
Edward Rosser United Kingdom 5 367 1.8× 20 0.2× 189 2.1× 40 0.6× 48 1.0× 8 515

Countries citing papers authored by Marc Capet

Since Specialization
Citations

This map shows the geographic impact of Marc Capet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Capet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Capet more than expected).

Fields of papers citing papers by Marc Capet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Capet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Capet. The network helps show where Marc Capet may publish in the future.

Co-authorship network of co-authors of Marc Capet

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Capet. A scholar is included among the top collaborators of Marc Capet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Capet. Marc Capet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuiker, Rob, Jules A. A. C. Heuberger, Marieke de Kam, et al.. (2023). Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations. British Journal of Clinical Pharmacology. 90(1). 321–335.
2.
Reiner‐Link, David, et al.. (2020). Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies. European Journal of Medicinal Chemistry. 191. 112150–112150. 2 indexed citations
3.
Levoin, Nicolas, Xavier Billot, Thierry Calmels, et al.. (2016). Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening. European Journal of Medicinal Chemistry. 125. 565–572. 10 indexed citations
4.
Levoin, Nicolas, Xavier Billot, Thierry Calmels, et al.. (2016). Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(21). 5263–5266. 5 indexed citations
5.
Capet, Marc, Thierry Calmels, Nicolas Levoin, et al.. (2015). Improving selectivity of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 26(3). 885–888. 6 indexed citations
6.
Levoin, Nicolas, Stéphane Krief, Thierry Calmels, et al.. (2013). Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 21(15). 4526–4529. 11 indexed citations
7.
Levoin, Nicolas, Thierry Calmels, Xavier Ligneau, et al.. (2013). Novel and highly potent histamine H3 receptor ligands. Part 3: An alcohol function to improve the pharmacokinetic profile. Bioorganic & Medicinal Chemistry Letters. 23(9). 2548–2554. 8 indexed citations
8.
Levoin, Nicolas, Thierry Calmels, Xavier Ligneau, et al.. (2011). Novel and highly potent histamine H3 receptor ligands. Part 2: Exploring the cyclohexylamine-based series. Bioorganic & Medicinal Chemistry Letters. 21(18). 5384–5388. 8 indexed citations
9.
Levoin, Nicolas, Thierry Calmels, Isabelle Berrebi‐Bertrand, et al.. (2011). Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity. Bioorganic & Medicinal Chemistry Letters. 21(18). 5378–5383. 19 indexed citations
10.
Jean, Mickaël, Jacques Renault, Nicolas Levoin, et al.. (2010). Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20(18). 5376–5379. 7 indexed citations
11.
12.
Amon, Michael, et al.. (2009). Fluorinated non-imidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(8). 2172–2175. 25 indexed citations
13.
Levoin, Nicolas, Thierry Calmels, Philippe Robert, et al.. (2008). Refined Docking as a Valuable Tool for Lead Optimization: Application to Histamine H3 Receptor Antagonists. Archiv der Pharmazie. 341(10). 610–623. 33 indexed citations
14.
Jean, Mickaël, Jacques Renault, Nicolas Levoin, et al.. (2008). A solid phase parallel synthesis of diverse amides as dopamine D3receptor ligands. Journal of Enzyme Inhibition and Medicinal Chemistry. 23(5). 588–592. 1 indexed citations
15.
Calmels, Thierry, Marc Capet, Isabelle Berrebi‐Bertrand, et al.. (2005). Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides. Bioorganic & Medicinal Chemistry. 13(6). 2009–2014. 13 indexed citations
16.
Petitet, François, et al.. (1997). Interaction of brain cannabinoid receptors with guanine nucleotide binding protein. Biochemical Pharmacology. 54(11). 1267–1270. 18 indexed citations
17.
Capet, Marc, et al.. (1995). A Two-Step Synthesis of Camphosultam. Synthetic Communications. 25(21). 3323–3327. 7 indexed citations
18.
Böhme, Georg Andrees, Philìppe Bertrand, Claude Guyon, et al.. (1994). The Ureidoacetamides, a Novel Family of Non‐peptide CCK‐B/Gastrin Antagonists. Annals of the New York Academy of Sciences. 713(1). 118–120. 10 indexed citations
19.
Burgevin, Marie‐Claude, et al.. (1994). Congo Red protects against toxicity of β-amyloid peptides on rat hippocampal neurones. Neuroreport. 5(18). 2429–2432. 39 indexed citations
20.
Bertrand, Philìppe, Georg Andrees Böhme, Christiane Durieux, et al.. (1994). Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists. European Journal of Pharmacology. 262(3). 233–245. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark J. Gemkow Breakdown of academic impact, for papers by Steffen Pockes Breakdown of academic impact, for papers by Norihiro Takenaga Breakdown of academic impact, for papers by Sandra L. Cockerham Breakdown of academic impact, for papers by Michael Berlin Breakdown of academic impact, for papers by Albert J. Uveges Breakdown of academic impact, for papers by Rolf Hohlweg Breakdown of academic impact, for papers by Kamil Kuder Breakdown of academic impact, for papers by Lawrence A. Black Breakdown of academic impact, for papers by Edward Rosser
Rankless by CCL
2026